Immunoassay Market (By Product: Reagents & Kits, Analyzer, Software and Services; By Technology: ELISA, Rapid Tests, ELISpot, Western Blotting, Radioimmunoassay; By Specimen: Blood, Saliva, Urine, Other; By Application: Infectious diseases, Endocrinology, Oncology, Bone And Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

The global immunoassay market size was exhibited at USD 32.49 billion in 2022 and is projected to hit around USD 51.38 billion by 2032, growing at a CAGR of 4.69% during the forecast period 2023 to 2032.

Immunoassay Market Size, 2023 to 2032

Key Pointers:

  • The North America dominated the market and captured more than 36.19% of the revenue share in 2022. 
  • The Asia Pacific is expected to be the fastest-growing region. 
  • By product, the kit and reagent segment dominated the market and generated more than 61.4% of the total market share in 2022. 
  • By product, the software and services segment is expected to grow at a CAGR of 5.69% from 2023 to 2032.
  • By technology, the ELISA segment dominated the market and capture more than 61.9% of the revenue share in 2022.
  • By application, the infectious disease segment dominated the market and generated more than 31.4% of the market share in 2022. 
  • By end user, the hospital & clinical segment will dominate the market and contribute more than 31.2% market share in 2022. 
  • By end user, the blood banks are expected to grow at a healthy CAGR from 2023 to 2032.

Immunoassay Market Report Scope

Report Coverage

Details

Market Size in 2023

USD 34.01 Billion

Market Size by 2032

USD 51.38 Billion

Growth Rate From 2023 to 2032

CAGR of 4.69%

Base Year

2022

Forecast Period

2023 to 2032

Segments Covered

By Product, By Technology, By Specimen, By Application and By End User

Market Analysis (Terms Used)

Value (US$ Million/Billion) or (Volume/Units)

Regional Scope

North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa

Key Companies Profiled

The major players operating in the immunoassay market are Abbott Laboratories, Danaher Corporation (Beckman Coulter), Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories, Inc., Becton, Dickinson, and Company, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Siemens Healthinners and Others.

 

Immunoassay is a test conducted to determine concentration of macromolecule in a solution using antibody or immunoglobulin. The macromolecule detected is known as analyte. Immunoassay is used to measure quantity of analytes in serum and urine for medical and research purposes. It is also used in qualitative, quantitative and radioactivity procedures to ensure accuracy of results obtained. High sensitivity and specificity of immunoassays are used to speed up the reactions.

Rising incidences of chronic & infectious disease and use of immunoassays in Oncology are factor propelling the growth of the world immunoassay market. In addition, technological advancements and sensitivity, cost effectiveness, & rapid analysis offered by immunoassays supplement the growth. However, low detection limit and implementation of excise duty by the U.S. Government are hindering the growth of this market. Expanding biotechnology & pharmaceutical industries and laboratory automation and emerging markets in Asia presents significant opportunities.

The world immunoassay market is segmented based on technology, product & services, application, end user, and geography. The technology segment is further classified into ELISA, fluorescence, colorimetric, chemiluminescence, rapid test, western blot, ELISPOT, and PCR. The products & services covered in the report are reagents & kits, analyzers, and software services. The applications discussed in the report are infectious disease, endocrinology, cardiology, oncology, and hematology. The end user segment is further classified into hospitals, clinical laboratories, blood banks, academic research centers, pharmaceutical companies, and biotechnology companies, and others. Worldly, the market is segmented into North America, Asia, Europe, and Latin America, Middle East and Africa (LAMEA).

The prominent manufacturers operating in the market are Roche Diagnostics Limited, Siemens Healthcare, Abbott Laboratories, Beckman Coulter, Ortho Clinical Diagnostics, BioMrieux, Bio-Rad Laboratories Inc., Alere Inc., Sysmex Corporation, and Becton, Dickinson & Company. Various strategies, such as expansions, collaborations, partnerships, mergers & acquisitions, expansions, joint ventures, and others have been adopted by prominent manufacturers to gain a strong foothold in the

Some of the prominent players in the Immunoassay Market include:

  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter)
  • Quidel Corporation
  • Ortho Clinical Diagnostics
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson, and Company
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthinners

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Immunoassay market.

By Product

  • Reagents & Kits
    • ELISA Reagents & Kits
    • Rapid Test Reagent & Kits
    • ELISpot Reagents & Kits
    • Western Blot Reagents & Kits
    • Other Reagents & Kits
  • Analyzer
    • By Type
      • Open-ended System
      • Closed-Ended System
    • By Purchased Mode
      • Rental Purchased
      • Outright Purchased
  • Software and Services

By Technology

  • ELISA
    • By generation
      • Third generation & Above
      • Second-generation & Below
  • Rapid Tests
  • ELISpot
  • Western Blotting
  • Radioimmunoassay
  • Other technologies

By Specimen

  • Blood
  • Saliva
  • Urine
  • Other Specimen

By Application

  • Infectious diseases
  • Endocrinology
  • Oncology
  • Bone and mineral disorders
  • Cardiology
  • Blood screening
  • Autoimmune Disorders
  • Allergy Diagnostics
  • Toxicology
  • Newborn Screening
  • Other Application

By End-User

  • Hospitals & Clinics
  • Clinical Laboratories
  • Pharmaceutical & Biotechnology Companies And Cro
  • Blood Banks
  • Research & Academic Laboratories
  • Home Care Setting

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global immunoassay market size was exhibited at USD 32.49 billion in 2022 and is projected to hit around USD 51.38 billion by 2032

The global immunoassay market is poised to grow at a CAGR of 4.69% from 2023 to 2032.

The major players operating in the immunoassay market are Abbott Laboratories, Danaher Corporation (Beckman Coulter), Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories, Inc., Becton, Dickinson, and Company, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Siemens Healthinners and Others.

North America region will lead the global immunoassay market during the forecast period 2023 to 2032.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Immunoassay Market 

5.1. COVID-19 Landscape: Immunoassay Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Immunoassay Market, By Product

8.1. Immunoassay Market, by Product, 2023-2032

8.1.1. Reagents & Kits

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Analyzer

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Software and Services

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Immunoassay Market, By Technology

9.1. Immunoassay Market, by Technology, 2023-2032

9.1.1. ELISA

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Rapid Tests

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. ELISpot

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Western Blotting

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Radioimmunoassay

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Other technologies

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Immunoassay Market, By Specimen 

10.1. Immunoassay Market, by Specimen, 2023-2032

10.1.1. Blood

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Saliva

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Urine

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Other Specimen

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Immunoassay Market, By Application

11.1. Immunoassay Market, by Application, 2023-2032

11.1.1. Infectious diseases

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Endocrinology

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Oncology

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Bone and mineral disorders

11.1.4.1. Market Revenue and Forecast (2020-2032)

11.1.5. Cardiology

11.1.5.1. Market Revenue and Forecast (2020-2032)

11.1.6. Blood screening

11.1.6.1. Market Revenue and Forecast (2020-2032)

11.1.7. Autoimmune Disorders

11.1.7.1. Market Revenue and Forecast (2020-2032)

11.1.8. Allergy Diagnostics

11.1.8.1. Market Revenue and Forecast (2020-2032)

11.1.9. Toxicology

11.1.9.1. Market Revenue and Forecast (2020-2032)

11.1.10. Newborn Screening

11.1.10.1. Market Revenue and Forecast (2020-2032)

11.1.11. Other Application

11.1.11.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Immunoassay Market, By End-User

12.1. Immunoassay Market, by End-User, 2023-2032

12.1.1. Hospitals & Clinics

12.1.1.1. Market Revenue and Forecast (2020-2032)

12.1.2. Clinical Laboratories

12.1.2.1. Market Revenue and Forecast (2020-2032)

12.1.3. Pharmaceutical & Biotechnology Companies And Cro

12.1.3.1. Market Revenue and Forecast (2020-2032)

12.1.4. Blood Banks

12.1.4.1. Market Revenue and Forecast (2020-2032)

12.1.5. Research & Academic Laboratories

12.1.5.1. Market Revenue and Forecast (2020-2032)

12.1.6. Home Care Setting

12.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 13. Global Immunoassay Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2020-2032)

13.1.2. Market Revenue and Forecast, by Technology (2020-2032)

13.1.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.1.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.5. Market Revenue and Forecast, by End-User (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.1.6.2. Market Revenue and Forecast, by Technology (2020-2032)

13.1.6.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.1.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.6.5. Market Revenue and Forecast, by End-User (2020-2032) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product (2020-2032)

13.1.7.2. Market Revenue and Forecast, by Technology (2020-2032)

13.1.7.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.1.7.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.7.5. Market Revenue and Forecast, by End-User (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.2. Market Revenue and Forecast, by Technology (2020-2032)

13.2.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.2.4. Market Revenue and Forecast, by Application (2020-2032) 

13.2.5. Market Revenue and Forecast, by End-User (2020-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)

13.2.6.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.2.7. Market Revenue and Forecast, by Application (2020-2032) 

13.2.8. Market Revenue and Forecast, by End-User (2020-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.9.2. Market Revenue and Forecast, by Technology (2020-2032)

13.2.9.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.2.10. Market Revenue and Forecast, by Application (2020-2032)

13.2.11. Market Revenue and Forecast, by End-User (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.12.2. Market Revenue and Forecast, by Technology (2020-2032)

13.2.12.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.2.12.4. Market Revenue and Forecast, by Application (2020-2032)

13.2.13. Market Revenue and Forecast, by End-User (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.14.2. Market Revenue and Forecast, by Technology (2020-2032)

13.2.14.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.2.14.4. Market Revenue and Forecast, by Application (2020-2032)

13.2.15. Market Revenue and Forecast, by End-User (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.2. Market Revenue and Forecast, by Technology (2020-2032)

13.3.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.3.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.5. Market Revenue and Forecast, by End-User (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)

13.3.6.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.3.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.7. Market Revenue and Forecast, by End-User (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.8.2. Market Revenue and Forecast, by Technology (2020-2032)

13.3.8.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.3.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.9. Market Revenue and Forecast, by End-User (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.10.2. Market Revenue and Forecast, by Technology (2020-2032)

13.3.10.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.3.10.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.10.5. Market Revenue and Forecast, by End-User (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.11.2. Market Revenue and Forecast, by Technology (2020-2032)

13.3.11.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.3.11.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.11.5. Market Revenue and Forecast, by End-User (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.2. Market Revenue and Forecast, by Technology (2020-2032)

13.4.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.4.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.5. Market Revenue and Forecast, by End-User (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)

13.4.6.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.4.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.7. Market Revenue and Forecast, by End-User (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.8.2. Market Revenue and Forecast, by Technology (2020-2032)

13.4.8.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.4.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.9. Market Revenue and Forecast, by End-User (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.10.2. Market Revenue and Forecast, by Technology (2020-2032)

13.4.10.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.4.10.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.10.5. Market Revenue and Forecast, by End-User (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.11.2. Market Revenue and Forecast, by Technology (2020-2032)

13.4.11.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.4.11.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.11.5. Market Revenue and Forecast, by End-User (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2020-2032)

13.5.2. Market Revenue and Forecast, by Technology (2020-2032)

13.5.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.5.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.5. Market Revenue and Forecast, by End-User (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.5.6.2. Market Revenue and Forecast, by Technology (2020-2032)

13.5.6.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.5.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.7. Market Revenue and Forecast, by End-User (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2020-2032)

13.5.8.2. Market Revenue and Forecast, by Technology (2020-2032)

13.5.8.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.5.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.8.5. Market Revenue and Forecast, by End-User (2020-2032)

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Danaher Corporation (Beckman Coulter)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Quidel Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Ortho Clinical Diagnostics

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Sysmex Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Bio-Rad Laboratories, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Becton, Dickinson, and Company

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. F. Hoffmann-La Roche AG

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Thermo Fisher Scientific, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Siemens Healthinners

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert